Skip to main content
OpenTrials

Clinical trial condition

Systemic Lupus Erythematosus

Explore clinical trials studying Systemic Lupus Erythematosus. Study availability and eligibility vary by location and protocol.

484 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Systemic Lupus Erythematosus trial results

Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT04895696

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Local Institution - 0100 Birmingham, Alabama, United States
  • Local Institution - 0123 Huntington Beach, California, United States
  • Local Institution - 0170 La Jolla, California, United States
  • Local Institution - 0159 La Palma, California, United States
View all 147 locations
View Trial Details
Active, Not Recruiting

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

NCT04877691

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Paradise Valley, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site El Cajon, California, United States
View all 140 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

NCT05639114

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group Llc Anniston, Alabama, United States
  • Providence Medical Center Burbank, California, United States
  • University of California San Diego La Jolla, California, United States
  • Millennium Clinical Trials Westlake Village, California, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)

NCT05624749

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group LLC Anniston, Alabama, United States
  • Advanced Medical Research La Palma, California, United States
  • University of California LA Los Angeles, California, United States
  • Homestead Assoc In Research Inc Homestead, Florida, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

NCT05798117

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Pessac, France
  • Novartis Investigative Site Strasbourg, France
View Trial Details
Active, Not Recruiting

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

NCT05540327

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • The Lundquist Institute at Harbor-UCLA Medical Center Torrance, California, United States
  • Bay Area Arthritis and Osteoporosis Brandon, Florida, United States
  • Advance Medical Research Center Miami, Florida, United States
  • Dawes Fretzin Dermatology Group, LLC Indianapolis, Indiana, United States
View all 122 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

NCT06544330

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Feinstein Institutes for Medical Research Manhasset, New York, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Active, Not Recruiting

A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus

NCT05835986

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Clinica De La Costa Barranquilla, Colombia
  • Hospital Pablo Tobon Uribe Medellín, Colombia
  • Oncomedica S.A. Montería, Colombia
  • Hôpital Saint Eloi Montpellier, France
View all 23 locations
View Trial Details

Related conditions